Russell H. Morgan Department of Radiology and Radiological Science, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Adv Drug Deliv Rev. 2012 Oct;64(13):1488-507. doi: 10.1016/j.addr.2012.07.008. Epub 2012 Jul 20.
Recent technological developments in biomedicine have facilitated the generation of data on the anatomical, physiological and molecular level for individual patients and thus introduces opportunity for therapy to be personalized in an unprecedented fashion. Generation of patient-specific stem cells exemplifies the efforts toward this new approach. Cell-based therapy is a highly promising treatment paradigm; however, due to the lack of consistent and unbiased data about the fate of stem cells in vivo, interpretation of therapeutic effects remains challenging hampering the progress in this field. The advent of nanotechnology with a wide palette of inorganic and organic nanostructures has expanded the arsenal of methods for tracking transplanted stem cells. The diversity of nanomaterials has revolutionized personalized nanomedicine and enables individualized tailoring of stem cell labeling materials for the specific needs of each patient. The successful implementation of stem cell tracking will likely be a significant driving force that will contribute to the further development of nanotheranostics. The purpose of this review is to emphasize the role of cell tracking using currently available nanoparticles.
近年来,生物医学领域的技术发展促进了针对个体患者的解剖学、生理学和分子水平数据的生成,从而为治疗提供了前所未有的个性化机会。生成患者特异性干细胞就是朝着这一新方法努力的典范。基于细胞的治疗是一种极具前景的治疗模式;然而,由于缺乏关于干细胞在体内命运的一致且无偏数据,因此对治疗效果的解释仍然具有挑战性,阻碍了该领域的进展。纳米技术的出现带来了广泛的无机和有机纳米结构,为跟踪移植的干细胞提供了更多的方法。纳米材料的多样性彻底改变了个性化纳米医学,并使干细胞标记材料能够根据每个患者的具体需求进行个体化定制。成功实施干细胞跟踪很可能成为一个重要的推动因素,有助于进一步发展纳米治疗诊断学。本文的目的是强调使用当前可用的纳米粒子进行细胞跟踪的作用。